CONFERENCE PROCEEDING
Pregnancy and postpartum course in women with thyrotropin-secreting
pituitary adenomas: Maternal and neonatal perspectives
More details
Hide details
1
Medical Services Department, Hygeia Hospital, Athens, Greece
2
Obstetrics and Gynaecology Department, Royal Sussex and County Hospital, University Sussex Hospital, Brighton, United Kingdom
3
Department of Midwifery, School of Health and Care Sciences, University of West Attica, Athens, Greece
4
Second Oncology Clinic, Theagenio Cancer Hospital of Thessaloniki, Thessaloniki, Greece
5
Second Department of Obstetrics and Gynaecology, Aretaieio University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
6
Endocrine Clinic, Evgenideion Hospital, National and Kapodistrian University of Athens, Athens, Greece
Publication date: 2025-10-24
Eur J Midwifery 2025;9(Supplement 1):A89
KEYWORDS
ABSTRACT
Background:
Thyrotropin-secreting pituitary adenomas (TSHomas) during pregnancy are
exceedingly rare and pose significant clinical challenges. Managing maternal
hyperthyroidism while ensuring optimal fetal development and addressing postpartum
recovery, requires a tailored, multidisciplinary approach.
Aim:
To examine maternal symptoms, pregnancy progression, delivery outcomes, neonatal
health, and postpartum lactation in women diagnosed with TSHomas during
pregnancy.
Methods:
A systematic review was conducted of all reported pregnancies affected by TSHomas
between 1993 and 2024. Eleven cases were identified. Extracted data included
maternal clinical presentation, management strategies, delivery outcomes, neonatal
health, and postpartum course.
Results:
With regard to maternal course, before diagnosis, 82% of women exhibited overt
hyperthyroid symptoms, including tachycardia, emotional lability, heat intolerance,
and tremors. Galactorrhea, often accompanied by menstrual irregularities, was
reported in 36%. During pregnancy, most women required treatment to manage
hyperthyroidism. Somatostatin analogs were used in 44% of cases, with close
monitoring to mitigate maternal and fetal risks. Two women experienced visual
disturbances due to tumor progression.
Postpartum, maternal symptoms generally improved with ongoing medical therapy or
delayed surgery. No cases of pituitary apoplexy occurred. Regarding neonatal
outcomes, ten of the eleven pregnancies resulted in live births; one was electively
terminated for non-medical reasons. Seventy three percent (73%) of deliveries
occurred at term, while three were preterm (34–36 weeks). No congenital anomalies
were observed. One neonate developed transient hypothyroidism. Birth weights
ranged between 2500 – 3400 grams. Finally, breastfeeding was successful in 36% of
cases. Postpartum use of somatostatin analogs, likely due to their prolactin-
suppressing effects, contributed to lactation difficulties. Supportive measures such as
lactation consultation were inconsistently reported but remain a critical component of
postpartum care.
Conclusion:
With timely diagnosis and coordinated care, pregnancies complicated by TSHomas
can result in favorable maternal and neonatal outcomes. Anticipating and managing
postpartum lactation challenges is essential for comprehensive care.